Issues related to the transfer of technology to developing countries, as well as the need for capacity building in the production of pharmaceuticals, are a serious omission from the draft regulation.
Issues related to the transfer of technology to developing countries, as well as the need for capacity building in the production of pharmaceuticals, are a serious omission from the draft regulation.